Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus: a population pharmacokinetic study.


Autoria(s): Smyth, J.M.; Collier, Paul; Darwish, M.; Millership, Jeffrey; Halliday, H.L.; Petersen, S.; McElnay, James
Data(s)

01/01/2004

Identificador

http://pure.qub.ac.uk/portal/en/publications/intravenous-indometacin-in-preterm-infants-with-symptomatic-patent-ductus-arteriosus-a-population-pharmacokinetic-study(06ab6ae5-ad70-4d37-b2cc-73b22e5b59cb).html

http://dx.doi.org/10.1111/j.1365-2125.2004.02139.x

http://www.scopus.com/inward/record.url?scp=4444382912&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Smyth , J M , Collier , P , Darwish , M , Millership , J , Halliday , H L , Petersen , S & McElnay , J 2004 , ' Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus: a population pharmacokinetic study. ' British Journal of Clinical Pharmacology , vol 58(3) , no. 3 , pp. 249-258 . DOI: 10.1111/j.1365-2125.2004.02139.x

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2736 #Pharmacology (medical) #/dk/atira/pure/subjectarea/asjc/3000 #Pharmacology, Toxicology and Pharmaceutics(all)
Tipo

article